Corporate-owned life insurance and bank-owned life insurance (COLI/BOLI) product lines are an important niche of the overall US-life insurance industry for 2016. These products, which provide a key funding mechanism for employee benefit programs, including executive compensation plans, tend to be underwritten by a limited number of carriers, leading to a high market share concentration.
For carriers in the COLI / BOLI markets, the issues, challenges and opportunities are somewhat different than what is currently being experienced for the larger, and more traditional, units focused on Individual and Group Life insurance.
Through this study, which included eight carriers that are currently actively selling new business, we are able to illustrate priorities for these important units as they plan for future growth and client support. The information contained in this report can be instructive for strategic planning, particularly in a line of business in which results appear to be very closely correlated to fundamental economic activity.
This report is a product of the Novarica Research Partners Program, which enables industry sponsors to underwrite surveys on topics of interest.
These surveys are conducted using the same methodologies and with the same respect for participant privacy as Novarica’s independent surveys and reports. Underwriting sponsors have input on question design and general characteristics of target respondents only.
Novarica conducts the survey and analyzes the results independently. Underwriting sponsors do not have draft approval or other ability to influence content of the final report.